SCHEMBL8536727

SCHEMBL8536727

Nc1ccc(-c2ncc[nH]2)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
CYP3A4 P08684 4/20 0.52
TSHR P16473 2/20 0.52
MAPK1 P28482 1/20 0.52
KDM4E B2RXH2 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
NPC1 O15118 1/20 0.50
USP2 O75604 1/20 0.50
LMNA P02545 1/20 0.50
TP53 P04637 1/20 0.50
POLB P06746 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
THRB P10828 1/20 0.50
HPGD P15428 1/20 0.50
RAB9A P51151 1/20 0.50
CACNA1B Q00975 1/20 0.50
APBA1 Q02410 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8137182 0.84 NISCH (0.53) ALDH1A1CYP3A4KDM4EMEN1KMT2A
SCHEMBL1719454 0.84 NISCH (0.53) ALDH1A1CYP3A4KDM4ENISCHMTOR
SCHEMBL1688469 0.79 NISCH (0.49) ALDH1A1CYP3A4KDM4ECACNA1BNISCH
SCHEMBL1838153 0.79 NISCH (0.58) ALDH1A1CYP3A4TSHRKDM4ENPC1
SCHEMBL8535895 0.79 NISCH (0.49) ALDH1A1CYP3A4TSHRKDM4ENISCH
SCHEMBL7060159 0.79 NISCH (0.49) ALDH1A1CYP3A4KDM4EMEN1KMT2A
Hydrochloric Acid SCHEMBL27817951 0.78 NISCH (0.56) ALDH1A1CYP3A4TSHRKDM4ENPC1
SCHEMBL3649556 0.76 NISCH (0.58) ALDH1A1CYP3A4TSHRKDM4ENPC1
SCHEMBL12714764 0.76 SMPD3 (0.60) ALDH1A1CYP3A4TSHRMAPK1KDM4E
SCHEMBL7425938 0.76 NISCH (0.45) ALDH1A1CYP3A4KDM4ENISCHMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020182990-A1 FUSED RING PYRIMIDONE DERIVATIVES FOR USE IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES Janssen Sciences Ireland Unlimited Company (IE) 2020-09-17 WO disclosed
EP-0857171-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1998-08-12 EP disclosed
WO-1997015555-A2 IMIDAZOLE DERIVATIVES AND THE USE THEREOF AS NITROGEN MONOXIDE SYNTHASE INHIBITORS SCHERING AKTIENGESELLSCHAFT (DE) 1997-05-01 WO disclosed